Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bio-Rad Acquires Cell Sorting System from Propel Labs

Published: Thursday, November 01, 2012
Last Updated: Thursday, November 01, 2012
Bookmark and Share
The simplicity of operation and price point of the S3 Cell Sorter will make cell sorting more accessible to new labs and core facilities that previously could not afford or support such an instrument.

What are the terms of the agreement?

Under the terms of agreement, Bio-Rad has acquired Propel Labs’ Avalon™ system, an automated, easy-to-use benchtop cell sorter. The new system will be provided and supported exclusively under the Bio-Rad brand as the S3 Cell Sorter.

Why did Bio-Rad acquire the Avalon system?S3CellSorter_ad_v1.gif

Cell sorting systems are used primarily in flow cytometry core facilities at academic, government, and industrial research institutions due to the size, high cost, and complexity of operation and maintenance. Bio-Rad and Propel Labs recognized the market need for a robust, low cost cell sorter to handle the workload challenges facing core facilities today. Additionally, the simplicity of operation and price point will make cell sorting more accessible to new labs and core facilities that previously could not afford or support such an instrument.

What does Tidar Sadeh, Propel Labs President and CEO, have to say about the agreement?

“We welcome the opportunity to partner with Bio-Rad to commercialize the S3 Cell Sorter. This cell sorting platform establishes a new benchmark in terms of price, performance, and ease-of-use and meets the needs of researchers working in cell biology today.”

Tell me about the S3 Cell Sorter (formerly the Avalon system).

Bio-Rad’s S3 Cell Sorter uses established jet-in-air technology and is equipped with one or two lasers and up to four fluorescent detectors as well as forward and side scatter detectors.

What are the advantages of the S3 Cell Sorter?

•    The new ProDrop™ technology automates setup and calibration in less than 30 minutes, which allows samples to be sorted at high speeds while maintaining sensitivity and high purity.

•    The completely internalized fluidics and temperature control system enable a compact size to fit in any lab.

•    Each S3 Cell Sorter is shipped with an intuitive, lab friendly ProAnalyzer™ software package. Installation and on-site training can be completed within three days.

What is Propel Labs?

Propel Labs, Inc. is a privately held biotechnology instrumentation company headquartered in Fort Collins, CO USA. Its principals helped develop the MoFlo™ cell sorter and the CyAn™ analyzer. The company focuses on the customer by quickly delivering innovative products and enhancing their research to advance patient care. For more information, visit www.propel-labs.com.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Researchers Develop Rapid, Cost-Effective Early Detection Method for Organ Transplant Injury
Chronix Biomedical and transplant expert Prof. Oellerich use Droplet Digital™ PCR to quantify early rejection biomarker.
Thursday, August 29, 2013
New Biomarker Could Reveal Alzheimer's Disease Years Before Onset
A new study has reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD).
Wednesday, August 14, 2013
Bio-Rad and Myriad RBM Partner to Develop Immunoassay Kits
Partnership to commercialize multiplex biomarker kits for life science research.
Wednesday, August 01, 2012
Bio-Rad Introduces new Pro-Human Diabetes Assay Panel
The Company has launched new Bio-Plex Pro™ Human Diabetes Assay Panels for its Bio-Plex® suspension array system.
Tuesday, June 24, 2008
Bio-Rad Announces Web Seminar Series
Web seminar series area includes Spectroscopy, Chromatography, ADME/Tox and Metabolomics.
Friday, May 05, 2006
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!